| Overview |
| bsm-90337r-50µL |
| Caspase 8 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM |
| Knockdown Validated |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human Caspase-8 |
| 200-250/479 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 841 |
| Q14790 |
| Caspase 8; FLICE; MCH5; MACH; Casp-8; Caspase 8 Apoptosis-Related Cysteine Peptidase; Caspase 8 Apoptosis-Related Cysteine Protease; MORT1-Associated Ced-3 Homolog; ICE-Like Apoptotic Protease 5; Apoptotic Cysteine Protease; Apoptotic Protease Mch-5; FADD-Like ICE; Caspase-8; CAP4; FADD-Homologous ICE/CED-3-Like Protease; FADD-Homologous ICE/Ced-3-Like Protease; MACH-Beta-1/2/3/4 Protein; MACH-Alpha-1/2/3 Protein; EC 3.4.22.61; ALPS2B; CASP-8 |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
Powered by Bioz